1 in 2 UK respondents were told they had something else before neuroendocrine cancer was found.

Base: 341 UK respondents
Source: SCAN 2025, International Neuroendocrine Cancer Alliance (INCA). UK results published by Neuroendocrine Cancer UK.
Read with care: Describes the 341 UK respondents, not all UK patients. Among the highest of the 17 countries compared, with Sweden and New Zealand close behind on smaller bases. INCA's tables do not mark the UK as different from the global number.